We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Medtronic, IBM Watson Join Forces With Israel VCs for Digital Health

Medtronic, IBM Watson Join Forces With Israel VCs for Digital Health

September 18, 2015

A partnership of four organizations that includes medtech giant Medtronic has been awarded a tender for a life sciences incubator in Haifa, Israel, with the aim of advancing digital medicine.

IBM Watson Tech, Pitango Venture Capital and Rambam MedTech make up the rest of the team that will establish the incubator, which will focus on, among other areas, telemedicine, wearable and implantable diagnostic sensors, advanced diagnostics, personalized medicine and medical devices that interact with the web.

“Digital medicine heralds a revolution in how people will receive medical services.

“We face a number of commercial and technological challenges, which demand complex integration of different disciplines,” says Dan Schwartzman, director of the new incubator, in a Rambam statement.

The incubator will be in a new Life Sciences Park that will include five buildings, with the main center scheduled for completion at the end of the year.

The tender is part of a fourth round of competitive procedures for selecting franchisees for an incubator to benefit the northern part of the country, according to a statement from Israel’s Ministry of Economy.

The incubator is part of a program administered by the Office of the Chief Scientist within Israel’s Ministry of Economy. Established in 1991, the goal of the Technological Incubators Program is to develop ideas into viable startup companies that can raise money from private investors.

Currently, there are 20 incubators in Israel. — Elizabeth Hollis

Commercial Operations

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • Vaccine needle

    Turkish Researchers Downgrade Sinovac’s COVID-19 Vaccine Efficacy Rate

  • Luminex logo

    Luminex Receives EUA for Expanded Respiratory Pathogen Panel, Clearing It for COVID-19

  • Acquires -Acquired

    Amgen to Buy Five Prime Therapeutics for $1.9 Billion

  • abbott-logo.gif

    Abbott Secures EUA for COVID-19 Combination Test

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing